TSTL - Ticker AI Digest

Tristel ๐Ÿ“ฐ 2
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Tristel in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
TSTL Data 2026-02-06 Preview Mode

Digested News

Today's Catalysts (TSTL) 2
TSTL 06:01
Tristel
Notice of Results
AI Expand: Explanation + Tables
Return to todayโ€™s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristelโ€™s investor website. The results presentation will also be available on the companyโ€™s website on the day of the announcement.
The provided text does not contain any financial or debt-related data for comparison. It is a notice of interim results and an announcement of upcoming investor and analyst briefings for Tristel PLC. Since there are no financial figures or debt details available in the text, I cannot create a year-on-year comparison table. However, I can provide you with a basic HTML table structure that you can use once you have the necessary financial data: < lang="en">Financial and Debt Comparison

Financial and Debt Comparison (Year-on-Year)

AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
TSTL 06:01
Tristel
Notice of Results
AI Expand: Explanation + Tables
Return to todayโ€™s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristelโ€™s investor website. The results presentation will also be available on the companyโ€™s website on the day of the announcement.
The provided text does not contain any financial or debt-related data for comparison. It is a notice of interim results and an announcement of upcoming investor and analyst briefings for Tristel PLC. Since there are no financial figures or debt details available in the text, I cannot create a year-on-year comparison table. However, I can provide you with a basic HTML table structure that you can use once you have the necessary financial data: < lang="en">Financial and Debt Comparison

Financial and Debt Comparison (Year-on-Year)

Metric20242025Change
RevenueยฃX,XXX,XXXยฃX,XXX,XXXX%
EBITDAยฃX,XXX,XXXยฃX,XXX,XXXX%
Net DebtยฃX,XXX,XXXยฃX,XXX,XXXX%
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
TSTL 06:01
Tristel
Positive H1 Trading Update & Directorate Change
AI Expand: Explanation + Tables
Return to todayโ€™s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel PLC, a manufacturer of infection prevention products, released a positive trading update for the first half (H1) of its fiscal year ending December 31, 2025. The company reported strong financial performance, including a 14% year-on-year revenue increase, maintained gross margins of 81%, and a 17% rise in adjusted EBITDA, with margins at 28%. Tristel remains debt-free, cash generative, and ended H1 with cash balances of ยฃ13.3m. The company is on track to meet full-year market expectations and internal targets, with continued growth in the U.S. market.
Additionally, Tristel announced a directorate change, with CEO Matt Sassone resigning to take a global leadership role at a large U.S. multinational. Sassone will remain in his position until the end of the financial year to ensure a smooth transition. The board has begun the search for a new CEO and expressed confidence in the existing management team to maintain business momentum. Both Sassone and Board Chair Bruno Holthof emphasized the companyโ€™s strong position, robust growth strategy, and compelling investment case. Tristel will announce its interim results in early March 2026.
Below is the HTML table code comparing the year-on-year financials and debt status based on the provided text:
Metric20242025Change
RevenueยฃX,XXX,XXXยฃX,XXX,XXXX%
EBITDAยฃX,XXX,XXXยฃX,XXX,XXXX%
Net DebtยฃX,XXX,XXXยฃX,XXX,XXXX%
MetricH1 2025H1 2024Year-on-Year Change
Revenuesยฃ (Not specified)ยฃ (Not specified)+14%
Gross Margins81%81%Maintained
Adjusted EBITDAยฃ (Not specified)ยฃ (Not specified)+17%
EBITDA Margins28%(Not specified)Comfortably ahead of 25% target
Cash Balances (as of 31 December)ยฃ13.3m(Not specified)Debt-free and cash generative
Debt StatusDebt-freeDebt-freeNo change
### Notes: 1. **Revenue and Adjusted EBITDA**: Exact figures for H1 2024 and H1 2025 are not provided in the text, so only percentage changes are included. 2. **Gross Margins**: Maintained at 81% year-on-year. 3. **EBITDA Margins**: H1 2025 is 28%, exceeding the target of at least 25%. 4. **Cash Balances**: H1 2025 cash balance is ยฃ13.3m, with no comparative figure for H1 2024 provided. 5. **Debt Status**: Tristel remains debt-free in both periods. This table summarizes the available financial and debt-related information from the text.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 4
TSTL 06:01
Tristel
Notice of Results
AI Expand: Explanation + Tables
Return to todayโ€™s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel plc, a global infection prevention company listed on the London Stock Exchanges AIM market (AIM: TSTL), has announced the release date for its interim results for the six-month period ending December 31, 2025. The results will be published on **Monday, March 2, 2026**.
Key events surrounding the announcement include
1. **Analyst Briefing**A London-based briefing for analysts will take place on March 2, 2026, at 11:00 AM. Registration details are available via Walbrook PR.
2. **Investor Presentations**Two presentations will be held on the same day
An online presentation via the Investor Meet Company platform at 9:30 AM, open to all existing and potential shareholders.
An in-person presentation in the City of London at 4:30 PM, followed by refreshments. Both events will feature CEO Matt Sassone and CFO Anna Wasyl.
Tristel, headquartered near Cambridge, specializes in infection prevention products using proprietary chlorine dioxide (ClO2) chemistry. The company operates globally, targeting double-digit revenue growth, a 25%+ EBITDA margin, and progressive dividend growth.
For further details, investors can contact Walbrook PR or visit Tristelโ€™s investor website. The results presentation will also be available on the companyโ€™s website on the day of the announcement.
The provided text does not contain any financial or debt-related data for comparison. It is a notice of interim results and an announcement of upcoming investor and analyst briefings for Tristel PLC. Since there are no financial figures or debt details available in the text, I cannot create a year-on-year comparison table. However, I can provide you with a basic HTML table structure that you can use once you have the necessary financial data: < lang="en">Financial and Debt Comparison

Financial and Debt Comparison (Year-on-Year)

TSTL 06:01
Tristel
Positive H1 Trading Update & Directorate Change
AI Expand: Explanation + Tables
Return to todayโ€™s catalyst cards, chart beacons and AI charts.
**Summary**
Tristel PLC, a manufacturer of infection prevention products, released a positive trading update for the first half (H1) of its fiscal year ending December 31, 2025. The company reported strong financial performance, including a 14% year-on-year revenue increase, maintained gross margins of 81%, and a 17% rise in adjusted EBITDA, with margins at 28%. Tristel remains debt-free, cash generative, and ended H1 with cash balances of ยฃ13.3m. The company is on track to meet full-year market expectations and internal targets, with continued growth in the U.S. market.
Additionally, Tristel announced a directorate change, with CEO Matt Sassone resigning to take a global leadership role at a large U.S. multinational. Sassone will remain in his position until the end of the financial year to ensure a smooth transition. The board has begun the search for a new CEO and expressed confidence in the existing management team to maintain business momentum. Both Sassone and Board Chair Bruno Holthof emphasized the companyโ€™s strong position, robust growth strategy, and compelling investment case. Tristel will announce its interim results in early March 2026.
Below is the HTML table code comparing the year-on-year financials and debt status based on the provided text:
Metric20242025Change
RevenueยฃX,XXX,XXXยฃX,XXX,XXXX%
EBITDAยฃX,XXX,XXXยฃX,XXX,XXXX%
Net DebtยฃX,XXX,XXXยฃX,XXX,XXXX%
MetricH1 2025H1 2024Year-on-Year Change
Revenuesยฃ (Not specified)ยฃ (Not specified)+14%
Gross Margins81%81%Maintained
Adjusted EBITDAยฃ (Not specified)ยฃ (Not specified)+17%
EBITDA Margins28%(Not specified)Comfortably ahead of 25% target
Cash Balances (as of 31 December)ยฃ13.3m(Not specified)Debt-free and cash generative
Debt StatusDebt-freeDebt-freeNo change
### Notes: 1. **Revenue and Adjusted EBITDA**: Exact figures for H1 2024 and H1 2025 are not provided in the text, so only percentage changes are included. 2. **Gross Margins**: Maintained at 81% year-on-year. 3. **EBITDA Margins**: H1 2025 is 28%, exceeding the target of at least 25%. 4. **Cash Balances**: H1 2025 cash balance is ยฃ13.3m, with no comparative figure for H1 2024 provided. 5. **Debt Status**: Tristel remains debt-free in both periods. This table summarizes the available financial and debt-related information from the text.

Today's AI

Today's AI Starts With News

2 live catalysts is opening Today’s AI for TSTL.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2026-02-06 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
2 Today
Front Of Desk
Tristel has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
10:57 Today's Catalyst Exercise of Share Options and Total Voting Rights
Single-Ticker Today's AI
TSTL signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Tristel. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Subscriber Unlock
Subscribe to unlock the full TSTL Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for TSTL on 2026-02-06.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
196.2M
Enterprise Value
152.8M
Public Float
96.1
Broker Target
472.333
Shares Out
48.0M
Long Interest
80
Short Interest
20
Exchange
LSE
Currency Code
GBX
ISIN
GB00B07RVT99
Market
LSE - AIM
Sector
Health Care Providers
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

2 live alerts now opens the financials desk for TSTL.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-02-06 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
2 Alerts
Front Of Desk
Tristel has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
10:57 Today's Alert Exercise of Share Options and Total Voting Rights
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.14
Ex Divi
2026-03-19
Earnings Date
2026-02-23
Net Debt
-2.8M
Cash
8.6M
EPS
0.16
Net Income
6.6M
Revenue
46.5M
Enterprise Value
152.8M
Trailing PE
25.5781
Forward PE
21.0084
Price Sales TTM
3.9615
Price Book MRQ
5.8216
EV Revenue
3.7922
EV EBITDA
14.5738
Financial Forecastist

Improving financial engine

Revenue is accelerating +22.5% against the prior comparable period. Net margin is stable by 0.7 pts. Net debt is coming down +204.1%.

Revenue +22.5% Net Income +28.3% FCF -1.4% Current Ratio 4.13x Forward Rev 0
Improving
Quarter Revenue
25.6M
+22.5%
vs prior comparable quarter
Net Margin
+15.4%
+0.7 pts
profitability pulse
Free Cash Flow
5.1M
-1.4%
cash conversion
Net Debt / EBITDA
-0.2x
-204.1%
lower is cleaner
Revenue Engine

Latest quarter printed 25.6M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 4.0M and the margin profile is stable. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 7.1M while net debt is -1.2M. The leverage stack is cleaning up.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q1 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2025
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
51.2M
Revenue Path
0.17
EPS / Earnings
Growth cue +0.0%
FY 2027
Consensus
56.2M
Revenue Path
0.20
EPS / Earnings
Growth cue +0.2%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 25.6M 4.0M 5.1M -1.2M
Q2 2025 23.9M 3.9M 4.9M -2.8M
Q4 2024 22.6M 2.7M 4.7M -5.8M
Q2 2024 21.0M 3.4M 4.8M -275.0K
Q4 2023 20.9M 3.1M 5.2M 1.2M
Q2 2023 18.5M 3.0M 2.8M -1.9M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 46.5M 6.6M 11.5M 9.5M
FY 2024 41.9M 6.5M 10.0M 10.1M
FY 2023 36.0M 4.5M 7.9M 6.1M
FY 2022 31.1M 987.0K 4.5M 4.3M
FY 2021 31.0M 3.7M 6.7M 4.7M

Structure DNA

Market Structure DNA

Income Anchor profile with trend mixed

Price is 57.9% through the 52-week range, -0.7% vs 50DMA and +1.2% vs 200DMA. 45.6% of the register is locked by institutions and insiders, leaving 54.4% free float. Capital rhythm reads semi-annual with forward yield near 3.7% and payout around 1.8%.

Trend mixed Institutional gravity Reliable income rhythm As Of 2026-04-19
Income Anchor
Structure Score
63.8 / 100
Income Anchor
Trend Stack
-0.7% / +1.2%
vs 50DMA / 200DMA
52W Position
57.9%
auction position inside the yearly range
Ownership Lock
45.6%
43.2% institutions | 2.4% insiders
Pressure Pocket
54.4% free float
Vendor short-float fields were not supplied
Capital Rhythm
Semi-Annual
Yield 3.7% | payout 1.8%
Trend Runway

Implied spot is 387.50 with the stock -0.7% vs 50DMA and +1.2% vs 200DMA. The tape is sitting 57.9% through the 52-week range, which frames the regime as trend mixed.

Ownership Register

Institutions hold about 43.2% and insiders about 2.4%, locking roughly 45.6% of the register and leaving 54.4% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads semi-annual with 2 event(s) in the last full year, a five-year average of 2.2, and stability score 80.0/100. Forward yield sits near 3.7% while payout is around 1.8%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Semi-Annual
Year Dividend Count Context
2026 1 Current partial year
2025 2 Full year
2024 2 Full year
2023 2 Full year
2022 3 Full year
2021 2 Full year
2020 2 Full year
2019 2 Full year

Structure Facts

Live Snapshot
Implied Spot
387.50
derived from market cap / shares
52W High
438.48
upper auction edge
52W Low
317.47
lower auction edge
Beta
0.29
volatility character
Shares Out
47.9M
fully diluted count
Shares Float
46.1M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
2026-03-19
-31 day(s) to ex-date
Dividend Pay
-
payment date not supplied
Last Split
-
split date not supplied

Capital Radar

Capital Regime
Building signal blend...
Smart Money Tilt
Public vs institutions
Target Conviction
Broker coverage pulse
Insider Pressure
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.0327
Institutions As Of
2026-04-20
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
3
Purchase TR1
1
Sale TR1
7
Broker Coverage Rows
3
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for TSTL, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-02-06 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
2 Today
Catalyst Pulse
Tristel has fresh news flow live now, so the tape is framing the chart workspace below.
10:57 Today's Catalyst Exercise of Share Options and Total Voting Rights
AI Charts Studio
TSTL Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-02-06 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Indicators0
Technicals0
AI Forecast -2.47%
RSI Gauge
Price Change
AI Forecast